stockrowSchrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
Follow SDGR
Alert me
Schrodinger, Inc. (SDGR) EBITDA
Schrodinger, Inc.'s EBITDA for fiscal 2025 was −$160.9M, compared with −$203.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$127.8M. Over the past ten years it has ranged from −$203.1M (fiscal 2024) to −$17.3M (fiscal 2017); the current reading is higher than 33% of that period. Schrodinger, Inc. ranks 40th of 43 Health Information Services companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | −$160.9M | — |
| FY2024 | −$203.1M | — |
| FY2023 | −$171.9M | — |
| FY2022 | −$142.5M | — |
| FY2021 | −$108.6M | — |
| FY2020 | −$57.3M | — |
| FY2019 | −$35.1M | — |
| FY2018 | −$25.1M | — |
| FY2017 | −$17.3M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | −$24.7M | — |
| Jun 2026 | −$40.1M | — |
| Mar 2026 | −$47.3M | — |
| Dec 2025 | −$15.7M | — |
| 27 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| TDOC Teladoc Health, Inc. compare | $214.9M |
| GDRX GoodRx Holdings, Inc. compare | $165.4M |
| OMCL Omnicell, Inc. compare | $144.5M |
| HSTM HealthStream, Inc. compare | $83.8M |
| CERT Certara, Inc. compare | $78.0M |
| PRVA Privia Health Group, Inc. compare | $63.8M |
| OMDA Omada Health, Inc. compare | $9.2M |
| HTFL Heartflow, Inc. compare | −$72.7M |
| SDGR Schrodinger, Inc. | −$127.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on SDGR
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement